skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: SAGE Premier 2007 remover idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study

Comi, G. ; Abramsky, O ; Arbizu, T ; Boyko, A ; Gold, R ; Havrdová, E ; Komoly, S ; Selmaj, K ; Sharrack, B ; Filippi, M

Multiple sclerosis, 2010-11, Vol.16 (11), p.1360-1366 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.